TNF-α was found in atherosclerotic plaques and correlates with CVD. Adalimumab treatment led to reduced blood lipid level, atherogenesis, and lower risk of cardiovascular events in patients with arthritis. It is not suitable for heart failure patients. This evidence concerns the gene TNF and heart failure.